|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Net changes in operating assets & liabilities: | |||||
| Prepaid expenses | |||||
| Interest and dividends earned in trust account | |||||
| Due to Sponsor | |||||
| Accrued expenses and other liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash withdrawn from Trust Account to redeem Public Shares | |||||
| Cash withdrawn from Trust Account for Trust Account service fees | |||||
| Investment of cash in Trust Account | |||||
| Proceeds from sales of marketable securities held in Trust Account to redeem public shares | |||||
| Proceeds from sales of marketable securities held in Trust Account for Trust account service fee | |||||
| Cash deposit to Trust Account for overdraft of Trust Account service fee | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds of Promissory Notes and Sponsor Loan | |||||
| Proceeds from sponsor loan | |||||
| Redemption of Public Shares | |||||
| Net cash used in financing activities | |||||
| Net decrease in cash | |||||
| Cash at beginning of period | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| subsequent measurement of ordinary shares subject to redemption (interest earned on trust account and extension deposits) | |||||
| Debt forgiveness by Sponsor | |||||
| Reduction of deferred underwriting commissions recorded in APIC | |||||
| Redemption liabilities accrued for ordinary shares rendered for redemption | |||||
Loading...